Press Release
A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today
SHENZHEN, CHINA – On the morning of 15 July 2025, China Medical System Holdings Limited (“CMS” or the “Group”) rang the ceremonial bell to mark its official listing on the Singapore Exchange Main Board (Stock Abbreviation: CMS, Stock Code: 8A8).
Nearly one hundred representatives from global professional institutions, shareholders, business partners and employees gathered to witness this strategic moment. Following its successful IPO on the Hong Kong Stock Exchange Main Board in September 2010 , CMS advances with formidable momentum onto the international capital platform, which will attract funds focusing on Asia-Pacific investments and local capital in Southeast Asia to optimize the shareholder structure. This listing also marks a significant milestone for the Group to deepen roots in emerging markets and advance industrial internationalization strategy.
At the listing ceremony, Chairman, Chief Executive Officer and President of CMS, Mr. Lam Kong stated: “The secondary listing in Singapore represents a crucial step in implementing CMS’s Asia-Pacific strategy, demonstrating our commitment to extending China’s market advantages across the entire APAC region while strengthening our presence in Southeast Asia and the Middle East. This move not only facilitates CMS’s comprehensive and sustainable development in Asia-Pacific markets, but also enhances our international influence and competitiveness, enabling us to serve broader patient populations with high-quality and affordable medication options.”
New CMS New Ascent
Over the 33-year journey, CMS has continuously challenged and surpassed itself through three strategic transformations to adapt to the external ecosystem: evolving from “China’s largest CSO” (1992-2010), to “transition from CSO to Pharma” (2010-2018), and since 2018, gradually establishing three core strategies of “Innovation-driven, Specialty Breakthroughs and Industrial Internationalization” to promote the upgrading and iteration of “New CMS”, accumulating momentum for takeoff.
CMS has established a comprehensive pharmaceutical product lifecycle management system, covering every stage from target identification to clinical development, product registration and commercialization. The Group focuses on FIC (First-in-Class) and BIC (Best-in-Class) innovative products, and has meticulously built a pipeline of approximately 40 innovative products with differentiated advantages, among which 5 innovative drugs have been approved and successfully commercialized in China. With the impact of VBP (Volume-Based Procurement) mostly cleared, CMS has entered a new cycle of high-quality and sustainable development driven by exclusive and innovative drugs.
In specialty fields, the Group focuses on cardio-cerebrovascular, gastroenterology, ophthalmology and skin health, continuously deepening product portfolios and expert networks. Notably, the Group’s skin health business “DERMAVON” has emerged as a leader in its sector and is proposed for an independent listing on the Main Board of the Hong Kong Stock Exchange.
A Pioneer in Industrial Internationalization Synergized Development Across the Entire “R&D, Manufacturing and Commercialization” Value Chain
Since 2022, CMS has initiated its “Industrial Internationalization” strategy by extending the Group’s advantages and resources from the Chinese market to emerging markets. Utilizing Singapore as the strategic pivot, the Group has established a localized cluster comprising CMS R&D, PharmaGend, and Rxilient, achieving synergized development across the entire pharmaceutical value chain from R&D to production and commercialization, driving deeper and broader market expansion across the Asia-Pacific region.
Internationalization of the Commercialization System: Rxilient serves as a platform for drug introduction, R&D and commercialization, operated by a professional and experienced localized team. Headquartered in Singapore, its business has expanded to 14 countries and regions including Malaysia, Thailand, Vietnam, the Philippines, Indonesia, and the Middle East, helping partners from China, the US, and Europe bring innovative drugs to emerging markets while introducing more high-quality and affordable treatment options to local markets. As of now, Rxilient has cumulatively submitted marketing applications for nearly 20 drugs and medical devices across Southeast Asia, the Middle East, Hong Kong, Macao and Taiwan, covering therapeutic areas such as dermatology, ophthalmology, oncology, autoimmune, and central nervous system.
Internationalization of the Production System: PharmaGend, as an international CDMO platform based in Singapore, has a site spanning 30,000 square meters and is capable of manufacturing dosage forms such as tablets and capsules, with plans to expand production lines for injections, ointments, and nasal sprays. The factory has been certified by international authorities such as the FDA and the HSA, demonstrating its high-standard pharmaceutical manufacturing capabilities for global export .
Structural factors including large population bases, healthcare insurance expansion and rising chronic disease burdens are transforming Southeast Asia, the Middle East and other emerging markets into new growth engines for the global pharmaceutical industry. Leveraging its integrated ecosystem, CMS is forming a novel model for Chinese pharmaceutical globalization – not only enabling incremental market conversion for its own products in emerging markets, but also providing global partners with a reliable one-stop solution, thereby generating additional growth momentum for the Group.
Looking ahead, CMS will continue advancing its three core strategies to build the long-term value system of “New CMS”. By persistently enhancing accessibility to pharmaceutical innovation, CMS aims to benefit more patients, achieve sustainable healthy development, and deliver substantial value returns to investors.
CMS Disclaimer and Forward-Looking Statements
This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.
This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.
Media Contact
Brand: China Medical System Holdings Ltd.
Contact: CMS Investor Relations
Email: ir@cms.net.cn
Website: https://web.cms.net.cn/en/home/
Source: China Medical System Holdings Ltd.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Lontto Expands Cement Block Machine Lineup with New High-Efficiency Models for Global Builders
United States, 15th Jul 2025, – Lontto, a leading manufacturer of industrial block and brick-making machinery, has announced the introduction of a new series of high-efficiency cement block machines. The latest models are designed to meet evolving demands in global construction markets, where reliability, material flexibility, and energy-conscious operation are becoming central requirements.

The release follows an extended period of development and testing at Lontto’s Chicago facility. The new machines incorporate modifications aimed at increasing operational efficiency, supporting diverse material usage, and minimizing mechanical downtime. Production lines have been updated to ensure consistent assembly and performance standards across all units.
Initial shipments have been sent to building sector clients in South America, Southeast Asia, and parts of West Africa. These regions are experiencing sustained investment in infrastructure and urban housing, where block production equipment plays a central role in construction timelines.
“The updated machines reflect technical priorities communicated by building contractors, site engineers, and equipment operators working in diverse environments,” said Chao Zhang, Chief Executive Officer of Lontto. “Durability, efficiency, and adaptability guided the engineering process behind each model in the expanded lineup.”
Lontto’s product range includes concrete block machines, mobile block units, and compressed earth block systems. The new additions are intended to complement existing offerings by addressing higher-volume requirements and varied site logistics. Each unit is designed with modular components, allowing for simplified maintenance and compatibility with multiple input materials, including cement blends, earth-based mixtures, and aggregate alternatives.
Industry data from international building associations continues to indicate a rise in mechanized block production, driven by increased urbanization and government-sponsored development efforts. Equipment that supports continuous output while minimizing waste and labor intensity is becoming an essential component of large-scale construction efforts.
To support deployment of the new models, Lontto has expanded its technical documentation and installation support protocols. These include on-site operator guidance, maintenance training, and region-specific operational advisories. Tools and support materials are available in multiple languages to assist clients across varying regulatory and industrial contexts.

Each unit in the new series is constructed using reinforced structural components and is subjected to post-assembly quality control inspections. Testing procedures focus on mechanical load endurance, production cycle reliability, and raw material integration. The machines are suitable for deployment in both rural and urban construction environments, with adjustments available for site-specific conditions.
Chao Zhang added, “Future development will continue to align with long-term shifts in global construction. Focus areas include automation, energy efficiency, and regional material adaptation. Technical partnerships and field data will continue to shape next-generation product planning.”
Lontto operates from its main facility at 4992 S Austin Ave in Chicago and exports equipment to over 30 countries. The company maintains long-term relationships with contractors, public works departments, and private construction firms involved in residential, industrial, and infrastructure projects.
The release of the new models marks the latest development in Lontto’s ongoing efforts to address functional challenges in construction equipment, particularly in sectors where production stability and machine longevity remain critical.
For more information regarding the new cement block machine models or related inquiries, contact Lontto at 708-260-8300 or via email at lontto66@gmail.com. The business is located at 4992 S Austin Ave, Chicago, IL 60638, USA.
Media Contact
Organization: Lontto
Contact
Person: Chao Zhang
Website:
https://www.block-machine.net/
Email:
lontto66@gmail.com
Contact Number: 17082608300
Address:4992 S Austin Ave
Address 2: Chicago, IL 60638
Country:United States
The post
Lontto Expands Cement Block Machine Lineup with New High-Efficiency Models for Global Builders appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Cloom Tech Debuts Heavy-Duty Truck Wire Harnesses Designed for Enhanced Durability and Fleet Efficiency
United States, 15th Jul 2025, – Cloom Tech, a leading manufacturer of custom wire harnesses and cable assemblies serving multiple industries, has announced the introduction of a new line of heavy-duty truck wire harnesses. This development addresses ongoing requirements in the commercial vehicle sector for reliable electrical systems capable of operating under high-load and high-stress conditions.

The new product line was developed to support manufacturers and fleet operators seeking improved durability in electrical components used in long-haul trucks, construction vehicles, and vocational fleets. These harnesses are constructed using reinforced materials and weather-resistant design principles intended to withstand mechanical stress, exposure to environmental elements, and continuous operational vibration.
Cloom Tech’s engineering and production teams designed the heavy-duty truck wire harnesses to align with both conventional and emerging vehicle platforms. Each unit is configured to support various onboard electrical systems, including power distribution, control modules, telematics interfaces, and advanced safety functions. Testing and quality checks are conducted at multiple stages to ensure that each harness meets performance standards required by commercial fleet operations.
“The increasing complexity of commercial vehicles demands greater reliability from electrical infrastructure,” said Ivy Zhao, Spokesperson. “The development of these heavy-duty truck wire harnesses reflects a response to consistent industry feedback regarding failure points, environmental stress, and diagnostic challenges.”
Design elements of the new harness line include abrasion-resistant jacketing, sealed connectors, and layout options that accommodate confined routing spaces commonly found in truck engine bays and chassis structures. The production process integrates custom specifications provided by vehicle manufacturers and fleet maintenance teams, allowing for fitment across a range of vehicle types and systems.
Industry data continues to show growing emphasis on uptime, serviceability, and total cost of ownership in the commercial trucking sector. In this context, the role of wire harness design extends beyond conductivity to include integration with monitoring systems, compatibility with diagnostic tools, and ease of replacement. Cloom Tech’s development strategy focused on achieving alignment with these evolving operational criteria.
The harnesses are built to support standardized communication systems such as CAN and LIN, which are frequently used in commercial vehicle networks. Modular design options allow for expanded functionality, supporting features such as adaptive cruise control, emission controls, and advanced driver assistance systems (ADAS). Integration with electronic logging devices (ELDs) and other regulatory components was also considered during the design phase.
Cloom Tech operates from a production facility in Medley, Florida, where it provides engineering design, prototyping, assembly, and inspection. The company’s background in supplying wire harnesses to aerospace, medical, and robotics applications has informed its approach to quality and precision for the heavy-duty trucking sector.

The launch of the heavy-duty truck wire harness product line is positioned as part of a broader strategy to support infrastructure requirements for advanced transportation technologies. Future releases are expected to focus on hybrid and electric vehicle compatibility, expanded routing customization, and component standardization across fleet models.
“These heavy-duty solutions are part of an ongoing effort to meet the long-term electrical challenges presented by next-generation vehicles,” added Ivy Zhao, Spokesperson. “Further investment in material science, connector innovation, and modular system architecture will guide the next phase of development across all transportation categories.”
In the coming year, Cloom Tech plans to expand engagement with truck manufacturers, maintenance providers, and system integrators to refine wire harness solutions based on operational feedback. The company will also continue research initiatives focused on increasing service intervals, reducing installation times, and optimizing harness performance across temperature and load extremes.
For further information regarding the heavy-duty truck wire harness manufacturers, contact Cloom Tech by phone at +1 863 434 8447. Inquiries can also be directed via email to sales@cloomtech.com. Cloom Tech is located at 9251 NW 112th Ave, Medley, FL 33178, USA.
Media Contact
Organization: Cloom Tech
Contact
Person: Ivy Zhao
Website:
https://cloomtech.com/
Email:
sales@cloomtech.com
Contact Number: 18634348447
Address:9251 NW 112th Ave
Address 2: Medley, FL 33178
Country:United States
The post
Cloom Tech Debuts Heavy-Duty Truck Wire Harnesses Designed for Enhanced Durability and Fleet Efficiency appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
HerbloomZ Launches SUPERBA MATCHA – A Probiotic Matcha Product Targeting Daily Stress Routines
From chef and founder May Hu, SUPERBA MATCHA is a probiotic matcha formulated with what the company describes as a ‘cortisol-first’ approach, supporting wellness routines designed to address daily stress.
HerbloomZ, a functional wellness brand founded by chef and nutritionist May Hu, has announced the release of SUPERBA MATCHA, a probiotic matcha formulation developed to support urban individuals facing stress-related challenges such as focus fluctuations and mental fatigue.
The development of the product was inspired by Hu’s personal experience with professional burnout, which led her to reevaluate how stress could be addressed through science-based approaches. Observing a lack of functional solutions targeting cortisol response, she conceptualized SUPERBA MATCHA, integrating insights from emerging research on stress physiology.
Most wellness products tend to offer surface-level symptom relief. In contrast, HerbloomZ positions SUPERBA MATCHA as a function-driven beverage designed with hormonal balance and emotional well-being in mind, aiming to bridge the gap between science-informed formulation and lifestyle integration.
The ‘Cortisol-First’ Strategy
HerbloomZ has adopted what it calls a “Cortisol-First Approach”, prioritizing stress response by considering the role of cortisol in daily wellbeing. According to the brand, symptoms such as abdominal weight retention, cognitive fatigue, and disrupted sleep may be associated with elevated or fluctuating cortisol levels, the body’s primary stress hormone.
The product is targeted at a demographic described by the company as high-performing professionals navigating constant work-life pressure. This audience often seeks science-backed, sustainable routines that address underlying stress factors rather than offering temporary relief.
An Innovation Engine: The ‘Gut-Brain Trifecta’
At the core of SUPERBA MATCHA is a formulation composed of three researched components the company calls the “Gut-Brain Trifecta”:
1. A 5-Strain Psychobiotic Blend: Each serving contains 20 billion CFU of five probiotic strains that have been studied for their potential roles in the gut-brain axis —a crucial communication pathway that, according to a growing body of scientific research, enables the gut microbiome to influence how the body responds to stress. This includes Bifidobacterium lactis, which has been studied for its potential association with cortisol modulation and emotional regulation.
2. Adaptogenic Herbs: A blend of Lion’s Mane, Poria, and Maitake—herbs traditionally valued for supporting cognitive well-being and overall balance.
3. Ceremonial Grade Matcha: Sourced from Yuyao, China, a region known for its longstanding tea heritage—the Matcha provides naturally occurring L-Theanine, an amino acid known for supporting calm, jitter-free focus without the crash associated with caffeine.
While traditional matcha is often consumed for its naturally calming properties, SUPERBA MATCHA is formulated with added probiotics and adaptogens, drawing from research in stress physiology and gut-brain signaling.
From Concept to Data-Backed Results
Before the launch, HerbloomZ tested its product through small-scale consumer events that introduced functional herbal pairings. Feedback from these gatherings, along with a subsequent 14-day pilot involving 50 participants, informed the formulation of SUPERBA MATCHA. Most participants reported improved calmness and focus, though results remain qualitative and exploratory. To ensure quality and safety, all HerbloomZ products undergo third-party testing and are verified to be free from heavy metals and pesticides. The company also emphasizes supply chain transparency, sourcing key ingredients from heritage tea regions such as Yuyao, and cultivating oolong tea in its own gardens in the Wuyi Mountains. All formulations are free from added sugars, artificial flavors, and fillers.
About HerbloomZ
HerbloomZ is a wellness-focused brand committed to developing safe, functional beverages. Its formulations combine scientifically studied probiotics with traditional herbal ingredients, aiming to support emotional balance in the rhythm of daily life. Rooted in the belief that inner calm can be cultivated through consistent and intentional routines, the brand offers sustainable, science-informed stress support designed to align with fast-paced urban lifestyles.
Media Contact
Organization: HerbloomZ Nutrition
Contact Person: Qili Yan
Website: https://herbloomzen.com/
Email:
hello@herbloomzen.com
City: Los Angeles
Country:United States
Release id:30770
The post HerbloomZ Launches SUPERBA MATCHA – A Probiotic Matcha Product Targeting Daily Stress Routines appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
-
Press Release4 days ago
AssetMint Launches Full-Stack Tokenization Infrastructure for Legally Compliant Real-World Assets
-
Press Release7 days ago
AnimalsSalecom Emerges as a Trusted Platform for Ethical Pet Companionship Connections
-
Press Release7 days ago
CodeGuru Accelerates Digital Transformation in the UAE with Cutting-Edge Web and Mobile App Solutions
-
Press Release1 week ago
Rewriting the Rules of Wealth- How Dr Mayowa Olusojis GO-PAS Blueprint Is Building a Financially Smarter World
-
Press Release1 week ago
WeTrade Earns Australian Financial Licence from ASIC
-
Press Release5 days ago
Launch of Ask Tenerife – The Ultimate Q&A Platform for Tenerife Enthusiasts
-
Press Release7 days ago
Michael Mitchell Named Certified Staffing Professional by the American Staffing Association
-
Press Release1 week ago
Mssse Encryption Group Sets New Standard in Digital Asset Finance with BBH Backing and US Regulatory Focus